HighVista Strategies LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 1335325 BOSTON, MA

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,659,308

+$43,987 QoQ

Shares Held

187,946

-3.1% QoQ

Ownership

0.221%

of shares outstanding

% of Portfolio

0.83%

of 13F equity value

Holder Rank

#49

of 172 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names. MLTX ranks #33 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,031	$15,062,511
2	RVMD	Revolution Medicines, Inc.	66,983	$12,544,576
3	DFTX	Definium Therapeutics, Inc.	242,884	$11,425,263
4	IMVT	Immunovant, Inc.	277,873	$10,706,446
5	PRAX	Praxis Precision Medicines, Inc.	30,210	$10,114,005
6	RLAY	Relay Therapeutics, Inc.	506,235	$9,471,656
7	PCVX	Vaxcyte, Inc.	149,739	$8,704,328
8	TNGX	Tango Therapeutics, Inc.	260,070	$8,129,788

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,659,308	187,946	-3.1%	Shares	Sole	2026-08-14
2026-03-31	$3,615,321	193,955	+917.7%	Shares	Sole	2026-05-15
2025-09-30	$136,653	19,059	-9.0%	Shares	Sole	2025-11-14
2025-06-30	$988,981	20,953	-51.9%	Shares	Sole	2025-08-14
2025-03-31	$1,701,146	43,541	0.0%	Shares	Sole	2025-05-15
2024-12-31	$2,357,745	43,541	0.0%	Shares	Sole	2025-02-14
2024-09-30	$2,195,337	43,541	+3.1%	Shares	Sole	2024-11-14
2024-06-30	$1,857,688	42,249	-29.3%	Shares	Sole	2024-08-14
2024-03-31	$3,002,196	59,769	0.0%	Shares	Sole	2024-05-15
2023-12-31	$3,609,449	59,769	0.0%	Shares	Sole	2024-02-14
2023-09-30	$3,406,833	59,769	-53.9%	Shares	Sole	2023-11-14
2023-06-30	$6,615,822	129,722	+6.2%	Shares	Sole	2023-08-14
2023-03-31	$2,613,879	122,201	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.